Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target

Lung and breast cancer are the leading causes of mortality in women worldwide. The discovery of molecular alterations that underlie these two cancers and corresponding drugs has contributed to precision medicine. We found that CCND2 is a common target in lung and breast cancer. Hypermethylation of t...

Full description

Bibliographic Details
Main Authors: Chin-Sheng Hung, Sheng-Chao Wang, Yi-Ting Yen, Tzong-Huei Lee, Wu-Che Wen, Ruo-Kai Lin
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:International Journal of Molecular Sciences
Subjects:
lung adenocarcinoma
triple-negative breast cancer (TNBC)
hypermethylation
Antrodia camphorata
antroquinonol D
CCND2
tumor suppressor gene
prognostic factor
circulating cell-free DNA
Online Access:http://www.mdpi.com/1422-0067/19/10/3096

Internet

http://www.mdpi.com/1422-0067/19/10/3096

Similar Items